Evidence map›Paper›PMID 39858389›Full record

ArticleAntibiotics (Basel, Switzerland)2025

A VersaTile Approach to Reprogram the Specificity of the R2-Type Tailocin Towards Different Serotypes of

Dorien Dams, Célia Pas, Agnieszka Latka, Zuzanna Drulis-Kawa, Lars Fieseler, Yves Briers

Abstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Dorien DamsDepartment of Biotechnology, Ghent University, Valentin Vaerwyckweg 1, 9000 Gent, Belgium.ORCID 0000-0002-8473-7813
Célia PasDepartment of Biotechnology, Ghent University, Valentin Vaerwyckweg 1, 9000 Gent, Belgium.ORCID 0000-0001-5671-174X
Agnieszka LatkaDepartment of Biotechnology, Ghent University, Valentin Vaerwyckweg 1, 9000 Gent, Belgium.ORCID 0000-0003-4492-497X
Zuzanna Drulis-KawaDepartment of Pathogen Biology and Immunology, University of Wroclaw, Przybyszewskiego 63, 51-148 Wroclaw, Poland.ORCID 0000-0002-4733-4660
Lars FieselerInstitute of Food and Beverage Innovation, Food Microbiology Research Group, Zurich University of Applied Sciences (ZHAW), Einsiedlerstrasse 35, 8820 Wädenswil, Switzerland.
Yves BriersDepartment of Biotechnology, Ghent University, Valentin Vaerwyckweg 1, 9000 Gent, Belgium.ORCID 0000-0001-7723-1040

Funding

Fonds Wetenschappelijk Onderzoek 1240021NFonds Wetenschappelijk Onderzoek 1251224NFonds Wetenschappelijk Onderzoek 1S79422N
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Escherichia coliKlebsiella pneumoniaephage–host interactionsphage tail-like bacteriocinR2 pyocinreceptor-binding proteintailocintailspikeVersaTile

Identifiers

PMID39858389
PMCPMC11762384

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.